Pfizer
-
{
- All
- News
- Videos
-
Pfizer Says Patient Safety Top Priority Amid Karnataka Fake Drug Probe
Pfizer stated that it continues to work closely with authorities to resolve the open queries, emphasising that its focus remains on protecting patients, safeguarding public health and maintaining confidence in the healthcare system.
-
Pfizer Q2 Tops Wall Street Estimates, Driven By Surging Sales Of Blood Thinner Eliquis
Outstanding worldwide demand for its popular blood thinner, Eliquis, together with fundamental cost-management initiatives, were the main driver of this outstanding company performance.
-
Pfizer Q1 Results: Net Profit Jumps 7%, Revenue Increases 8% To Rs 653 Crore
Pfizer Q1 Results: Bottom line grew to Rs 205 crore, up from Rs 192 crore in the corresponding quarter of the previous fiscal year, driven by healthy operational metrics and consistent top-line growth.
-
One Injection A Month For Weight Loss? Pfizer's New Obesity Drug Explained
The natural GLP-1 hormone survives in the body for only a few minutes before it is broken down. Drug developers overcome this limitation through advanced molecular engineering techniques.
-
"Felt I Was Dying": Musk Backs Claim Covid Jab Killed Thousands In Germany
Dr Helmut Sterz, a former Pfizer toxicologist, raised concerns about how Pfizer’s Comornaty mRNA vaccine was developed and tested in a quick manner.
-
Stocks To Buy: Sun Pharma, Cipla, Rainbow Among Systematix Top Picks In Healthcare Space Post Q2 Results
Systematix’s top picks for the sector include Sun Pharma, Cipla, Ajanta Pharma among others - Check full list.
-
Pfizer Share Price Jumps Over 6% As Q2 Net Profit Increases
Pfizer Ltd. share price rose as much as 6.45% to Rs 5,339 apiece, the highest level since Oct 30.
-
Pharma Sector Sees Modest Growth Amid US Headwinds; Sun Pharma, Cipla Among ICICI Securities' Top Picks
Pharma Q2 Resulte Preview: ICICI Securities remains cautious on the near-term outlook for pharma sector citing US tariffs uncertainty, NLEM price revision in 2026.
-
Trump Announces Pfizer Deal Offering Discounts On Medicines Via 'TrumpRx' Website
Pfizer has agreed to lower the cost of prescription drugs for Medicaid under a deal struck with the Trump administration, President Donald Trump said Tuesday as he promised similar deals with other drugmakers under the threat of tariffs.
-
Pfizer Gets Three-Year Reprieve From Trump Tariffs
Pfizer will sell some drugs at a 50% average discount on a direct-to-consumer website called TrumpRx.
-
Pfizer Stock Rises On Report Of Drug-Pricing Deal With Trump Administration
The pharma manufacturer will sell its drugs at a lower price to the US Medicaid Insurance Program as part of a deal with Trump to push forward his "most-favoured nations" policy.
-
Pfizer Defends Covid Shot, Says Trump Deserves Nobel Prize
Vaccines have become a political flashpoint in recent years, with pundits questioning widely accepted evidence about their safety and efficacy.
-
Pfizer Q1 Results: Profit Climbs 27%, Margin Expands
The drugmaker's revenue rose 7.1% to Rs 603.05 crore.
-
Pfizer Launches Next-Gen Vaccine For Pneumococcal Disease
PCV20 will be available as a single-shot vaccine and those vaccinated with PCV20 may not need a second dose, the drug maker said.
-
Sun Pharma, Cipla And More — Nirmal Bang's Top Stock Picks In Pharma Pack; Q1 Results Preview
Nirmal Bang expects Ajanta Pharma, Dr. Reddy's, JB Chemicals, Eris, Sun Pharma, and Lupin to outperform the IPM.
-
Pfizer Says Patient Safety Top Priority Amid Karnataka Fake Drug Probe
Pfizer stated that it continues to work closely with authorities to resolve the open queries, emphasising that its focus remains on protecting patients, safeguarding public health and maintaining confidence in the healthcare system.
-
Pfizer Q2 Tops Wall Street Estimates, Driven By Surging Sales Of Blood Thinner Eliquis
Outstanding worldwide demand for its popular blood thinner, Eliquis, together with fundamental cost-management initiatives, were the main driver of this outstanding company performance.
-
Pfizer Q1 Results: Net Profit Jumps 7%, Revenue Increases 8% To Rs 653 Crore
Pfizer Q1 Results: Bottom line grew to Rs 205 crore, up from Rs 192 crore in the corresponding quarter of the previous fiscal year, driven by healthy operational metrics and consistent top-line growth.
-
One Injection A Month For Weight Loss? Pfizer's New Obesity Drug Explained
The natural GLP-1 hormone survives in the body for only a few minutes before it is broken down. Drug developers overcome this limitation through advanced molecular engineering techniques.
-
"Felt I Was Dying": Musk Backs Claim Covid Jab Killed Thousands In Germany
Dr Helmut Sterz, a former Pfizer toxicologist, raised concerns about how Pfizer’s Comornaty mRNA vaccine was developed and tested in a quick manner.
-
Stocks To Buy: Sun Pharma, Cipla, Rainbow Among Systematix Top Picks In Healthcare Space Post Q2 Results
Systematix’s top picks for the sector include Sun Pharma, Cipla, Ajanta Pharma among others - Check full list.
-
Pfizer Share Price Jumps Over 6% As Q2 Net Profit Increases
Pfizer Ltd. share price rose as much as 6.45% to Rs 5,339 apiece, the highest level since Oct 30.
-
Pharma Sector Sees Modest Growth Amid US Headwinds; Sun Pharma, Cipla Among ICICI Securities' Top Picks
Pharma Q2 Resulte Preview: ICICI Securities remains cautious on the near-term outlook for pharma sector citing US tariffs uncertainty, NLEM price revision in 2026.
-
Trump Announces Pfizer Deal Offering Discounts On Medicines Via 'TrumpRx' Website
Pfizer has agreed to lower the cost of prescription drugs for Medicaid under a deal struck with the Trump administration, President Donald Trump said Tuesday as he promised similar deals with other drugmakers under the threat of tariffs.
-
Pfizer Gets Three-Year Reprieve From Trump Tariffs
Pfizer will sell some drugs at a 50% average discount on a direct-to-consumer website called TrumpRx.
-
Pfizer Stock Rises On Report Of Drug-Pricing Deal With Trump Administration
The pharma manufacturer will sell its drugs at a lower price to the US Medicaid Insurance Program as part of a deal with Trump to push forward his "most-favoured nations" policy.
-
Pfizer Defends Covid Shot, Says Trump Deserves Nobel Prize
Vaccines have become a political flashpoint in recent years, with pundits questioning widely accepted evidence about their safety and efficacy.
-
Pfizer Q1 Results: Profit Climbs 27%, Margin Expands
The drugmaker's revenue rose 7.1% to Rs 603.05 crore.
-
Pfizer Launches Next-Gen Vaccine For Pneumococcal Disease
PCV20 will be available as a single-shot vaccine and those vaccinated with PCV20 may not need a second dose, the drug maker said.
-
Sun Pharma, Cipla And More — Nirmal Bang's Top Stock Picks In Pharma Pack; Q1 Results Preview
Nirmal Bang expects Ajanta Pharma, Dr. Reddy's, JB Chemicals, Eris, Sun Pharma, and Lupin to outperform the IPM.
